Akums Drugs and Pharmaceuticals's total inventories for the quarter that ended in Mar. 2026 was ₹7,557 Mil. Akums Drugs and Pharmaceuticals's average total inventories from the quarter that ended in Dec. 2025 to the quarter that ended in Mar. 2026 was ₹3,779 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Akums Drugs and Pharmaceuticals's Net-Net Working Capital per share for the quarter that ended in Mar. 2026 was ₹34.13.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Akums Drugs and Pharmaceuticals's Days Inventory for the
three
months ended in Mar. 2026 was 52.20.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Akums Drugs and Pharmaceuticals's Inventory Turnover for the quarter that ended in Mar. 2026 was 1.75.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Akums Drugs and Pharmaceuticals's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.33.
Akums Drugs and Pharmaceuticals (NSE:AKUMS) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
Akums Drugs and Pharmaceuticals's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2026 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Akums Drugs and Pharmaceuticals's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
Akums Drugs and Pharmaceuticals Total Inventories Related Terms
Akums Drugs and Pharmaceuticals Total Inventories Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Akums Drugs and Pharmaceuticals Total Inventories Chart
Akums Drugs and Pharmaceuticals Total Inventories Calculation
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
Akums Drugs and Pharmaceuticals (NSE:AKUMS) has a Total Inventories of ₹7,557 Mil as of Mar. 2026. The total amount of inventory as recorded on a company's balance sheet. View historical data for Akums Drugs and Pharmaceuticals and its competitors.
Is Akums Drugs and Pharmaceuticals' Total Inventories too high?
Akums Drugs and Pharmaceuticals' current Total Inventories is ₹7,557 Mil. Overall, Akums Drugs and Pharmaceuticals has a GF Score™ of 48/100, reflecting its overall financial health beyond just this single metric.
How does Akums Drugs and Pharmaceuticals' Total Inventories compare to ZTS and UTHR?
Akums Drugs and Pharmaceuticals' Total Inventories of ₹7,557 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Drug Manufacturers company?
A good Total Inventories depends on the Drug Manufacturers industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Akums Drugs and Pharmaceuticals and its competitors. Akums Drugs and Pharmaceuticals's current Total Inventories is ₹7,557 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Akums Drugs and Pharmaceuticals stock overvalued right now?
Akums Drugs and Pharmaceuticals (NSE:AKUMS) has a current Total Inventories of ₹7,557 Mil. The current Total Inventories is ₹7,557 Mil. Akums Drugs and Pharmaceuticals' overall GF Score™ is 48/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Akums Drugs and Pharmaceuticals (NSE:AKUMS), the current Total Inventories is ₹7,557 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Akums Drugs and Pharmaceuticals Business Description
Akums Drugs and Pharmaceuticals Ltd a pharmaceutical contract development and manufacturing organization offering a comprehensive range of pharmaceutical products and services in India and overseas. Its services include formulation research and development (R&D), preparation and filing of regulatory dossiers in the Indian and Outside markets, and other testing services. It is also engaged in the manufacturing and sale of branded pharmaceutical formulations and active pharmaceutical ingredients (APIs). It operates in five segments: Contract Development and Manufacturing Operations, Active Pharmaceutical Ingredient (API), Domestic Branded formulations, International Branded Formulations, and Trade generics. Key revenue is generated from Contract Development and Manufacturing Operations.
48GF Score
Get the complete analysis for NSE:AKUMS
Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:AKUMS has been successfully added to your 
